164
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

HTR1A Gene Polymorphism in Type 2 Diabetes Mellitus Comorbid with Major Depressive Disorder in a Chinese Population

&
Pages 1597-1604 | Published online: 25 May 2022

References

  • Williams DM, Jones H, Stephens JW. Personalized Type 2 Diabetes Management: an Update on Recent Advances and Recommendations. Diabetes Metab Syndrome Obesity. 2022;15:281–295. doi:10.2147/DMSO.S331654
  • Federation ID. IDF Diabetes Atlas. 8th. Federation ID; 2017.
  • Cho NH, Shaw JE, Karuranga S, et al. Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281.
  • Group NDR. A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China. Zhonghua Nei Ke Za Zhi. 1981;20:678–683.
  • Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017;317:2515–2523.
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553.
  • Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005;28:1339–1345.
  • Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–1078.
  • Brown LC, Majumdar SR, Newman SC, Johnson JA. History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care. 2005;28:1063–1067.
  • Campayo A, de Jonge P, Roy JF, et al. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry. 2010;167(5):580–588. doi:10.1176/appi.ajp.2009.09010038
  • Arroyo C, Hu FB, Ryan LM, et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care. 2004;27(1):129–133. doi:10.2337/diacare.27.1.129
  • Kumari M, Head J, Marmot M. Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Intern Med. 2004;164(17):1873–1880. doi:10.1001/archinte.164.17.1873
  • Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and Risk for Onset of Type II Diabetes: a prospective population-based study. Diabetes Care. 1996;19(10):1097–1102. doi:10.2337/diacare.19.10.1097
  • Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–2486. doi:10.1007/s00125-010-1874-x
  • Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23:1165–1173.
  • Brieler JA, Lustman PJ, Scherrer JF, Salas J, Schneider FD. Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression. Fam Pract. 2016;33:30–36.
  • Newman-Tancredi A, Depoortere RY, Kleven MS, Kolaczkowski M, Zimmer L. Translating biased agonists from molecules to medications: serotonin 5-HT1A receptor functional selectivity for CNS disorders. Pharmacol Ther. 2022;229:107937.
  • Martin V, Mathieu L, Diaz J, et al. Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment. J Psychiatry Neurosci. 2020;45:344–355.
  • Prabhakar V, Gupta D, Kanade P, Radhakrishnan M. Diabetes-associated depression: the serotonergic system as a novel multifunctional target. Indian J Pharmacol. 2015;47:4–10.
  • Dong ZQ, Li XR, He L, He G, Yu T, Sun XL. 5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients. Neuropsychiatr Dis Treat. 2016;12:1623–1629.
  • Kim K, Oh CM, Ohara-Imaizumi M, et al. Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state. Endocrinology. 2015;156:444–452.
  • Xu Z, Chen Z, Shen T, et al. The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy. Psychiatry Clin Neurosci. 2022;76:51–57.
  • Asad S, Nikamo P, Gyllenberg A, Bennet H, Hansson O, Wierup N. HTR1A a novel type 1 diabetes susceptibility gene on chromosome 5p13-q13. PLoS One. 2012;7:e35439.
  • Seney ML, Glausier J, Sibille E. Large-Scale Transcriptomics Studies Provide Insight Into Sex Differences in Depression. Biol Psychiatry. 2022;91:14–24.
  • Wu Y, Zhu B, Chen Z, et al. Prevalence and predisposing factors of depressive symptoms in patients with stable coronary artery disease: a cross-sectional single-center study. Aging. 2019;11:3958–3968.
  • Zhu M, Li Y, Luo B, Cui J, Liu Y, Liu Y. Comorbidity of Type 2 Diabetes Mellitus and Depression: clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease. Front Cardiovascular Med. 2022;9:861110.
  • Zhao X, Huang Y, Li J, et al. Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis. Int Clin Psychopharmacol. 2012;27:314–320.
  • Takekita Y, Fabbri C, Kato M, et al. HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: a Meta-Analysis. int j neuropsychopharmacol. 2016;2:19.
  • Kishi T, Yoshimura R, Fukuo Y, et al. The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2013;263:105–118.
  • Cunningham AM, Santos TL, Gutzeit VA, Hamilton H, Hen R, Donaldson ZR. Functional Interrogation of a Depression-Related Serotonergic Single Nucleotide Polymorphism, rs6295, Using a Humanized Mouse Model. ACS Chem Neurosci. 2019;10:3197–3206.
  • Dong GZ, Zhang QY, Jiao YW, et al. The contribution of type 2 diabetes mellitus to hypothalamic inflammation and depressive disorders in young patients with obesity. Ann Translational Med. 2022;10:134.